MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.crohns.2013.03.004

Медицинская библиотека · Journal of Crohn's & colitis · 2013

Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.

Abreu Cândida, Magro Fernando, Santos-Antunes João, Pilão Artur, Rodrigues-Pinto Eduardo, Bernardes José, Bernardo Alexandra, Magina Sofia, Vilas-Boas Filipe, Lopes Susana, Macedo Guilherme, Sarmento António

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: An increased incidence of tuberculosis (TB) in patients under anti-TNF-α therapy has been reported, but outcome compared with TB in the general population are unknown.

METHODS

Patients who had active tuberculosis while taking anti-TNF-α drugs were studied and compared with a control group of community-acquired TB matched for sex, age and data of TB.

RESULTS

Twenty-five cases of TB were reported from a cohort of 765 patients under anti-TNF-α from 2001 to 2012. The incidence of TB per 100,000 patient-years was estimated to be 1337, 792 and 405 respectively for those on infliximab, adalimumab and etanercept. Twelve patients had inflammatory bowel disease, ten had rheumatologic diseases and three had psoriasis. From the 17 patients screened for latent TB before anti-TNF-α, three were treated with isoniazid. TB was diagnosed 1-108 months after starting anti-TNF-α, being the median time six, seven and 89 months respectively for those on infliximab, adalimumab and etanercept. Sixty per cent of the cases had extra-pulmonary TB. No deaths occurred in the case groups, while two died in control TB patients. Patients on anti-TNF-α drugs had more frequent extra-pulmonary TB, fever on presentation, higher mean C-reactive protein and lower positive rate of acid-fast bacilli.

CONCLUSIONS

TB may still occur in those with negative testing, some of them probably representing new infections instead of reactivations. Three out of 25 patients had TB in spite of previously treated LTB, although, the outcome of TB was not worse than in the general population.

Для цитирования: Abreu Cândida, Magro Fernando, Santos-Antunes João, Pilão Artur, Rodrigues-Pinto Eduardo, Bernardes José, Bernardo Alexandra, Magina Sofia, Vilas-Boas Filipe, Lopes Susana, Macedo Guilherme, Sarmento António. Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.. Journal of Crohn's & colitis. 2013. DOI: 10.1016/j.crohns.2013.03.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.